Stay updated on FLX475 Dose Escalation Trial in Combination With Pembrolizumab

Sign up to get notified when there's something new on the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page.
Latest website image capture
Clouds background image

Latest updates to the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page

  1. Check
    7 days ago
    Change Detected
    Summary
    No additions or deletions are observed between the two screenshots; the page content and layout appear unchanged.
    Difference
    0.0%
    Check dated 2026-03-14T03:44:53.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3, representing a minor metadata update.
    Difference
    0.0%
    Check dated 2026-03-06T22:12:19.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The changes consist of an internal software revision update from v3.4.1 to v3.4.2; no content related to the study details, eligibility, or results appears to be altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:51:15.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; this is a minor metadata change with no impact on the study details or functionality.
    Difference
    0.0%
    Check dated 2026-02-05T23:44:40.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.3.3 updated to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T04:16:42.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Added a Results Submitted status and expanded the Locations section to include multiple study sites across the United States and Australia. The expanded location list includes Arizona, California, Connecticut, District of Columbia, Florida, Georgia, Illinois, Kentucky, Maryland, Massachusetts, Michigan, New Mexico, New York, North Carolina, Texas, Washington, Victoria, and Western Australia.
    Difference
    2%
    Check dated 2025-12-24T14:56:35.000Z thumbnail image

Stay in the know with updates to FLX475 Dose Escalation Trial in Combination With Pembrolizumab

Enter your email address, and we'll notify you when there's something new on the FLX475 Dose Escalation Trial in Combination With Pembrolizumab page.